Medimmune finds target against systemic sclerosis

by Biotech Newsroom


The team headed by Devon Taylor identified a set of CD4-positive T-cells, which express the protein inducible costimulator (ICOS) in human skin, which contributes to systemic sclerosis. The serious inflammatory autoimmune disease leads to fibrosis of the skin and internal organs including the lungs, heart and kidneys.

Blocking these cells with an ICOS antibody or an IL-21 inhibitor ameliorated disease in an inducible mouse model mimicking systemic scleroses. The mechanism that leads to systemic sclerosis also involved matrix metalloproteinase 12, the researchers reported in Science Translational Medicine.

As CD4+ ICOS-expressing T cells with a…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC